yue junhan

1 clinical trials · Sponsor

Record	Firm	Date
Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer (NCT06176885)	yue junhan	2023-12-20

Every clearance here is in the API, with alerts when new ones post.